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Japon. June 1986 (Lever et al., 1983) . hexuronic acid positive materials were eluted at void volume (Fig. 1, top panels of A, B and C). When the D1 fraction was treated with alkaline borohydride and analyzed by means of a Sepharose CL-6B column, the peak at void volume disappeared and a new peak appeared at Kd=0.27 in case (A) and 0.30 in case (B) (Fig. 1, middle panels of  A and B) , suggesting that the glycosaminoglycan was covalently linked with protein because alkaline borohydride treatment was known to release glycosaminoglycan from proteoglycan by an elimination reaction. From the results of chromatography of chondroitin sulfate of known molecular weight (Wasteson, 1971) , the molecular size of the single chain species of glycosaminoglycan was estimated to be approximately 77,000 for case (A) and 66,000 for case (B). The alkaline borohydride treatment was not performed on the specimen obtained from case (C), because of the paucity of the materials. When the D1 fraction was digested with chondroitin ABC lyase, the peaks representing a high molecular form of hexuronic acid positive materials disappeared and a big peak appeared at Vt (Fig. 1 sulfate (HS) proteoglycans comprising 34% in case (A) and 17% in case (B) of the total proteoglycans. In case (C), no peak representing HS proteoglycan was observed. These results indicated that CS/DS proteoglycans were accumulated in all the three and HS proteoglycans in two out of three biopsied specimens obtained from the involved skin of PTM, but not in those without PTM. Fig. 2 shows the analysis of 35S-labeled proteoglycans synthesized by fibroblasts from PTM and normal skin in cell cultures. The radioactive materials recovered in D1 fraction were analyzed by Sepharose CL-6B chromatography. When the untreated D1 fraction was applied to the column, the 35S-radioactivity was eluted in two peaks , one at void volume and the other at Kd=0.65 (case A with PTM) or 0.57 (case B with PTM and normal) (Fig. 2 , top panels of A, B and C). When treated with alkaline borohydride and analyzed, radioactivity at void volume disappeared and that at 0.65 (case A) or 0.57 (case B and normal) was increased (Fig. 2 , middle panels of A, B and normal) suggesting that the peak at void volume represents proteoglycan and that at Kd=0.65 (case A) or 0.57 (case B and normal) represents the single glycosaminoglycan chain. The molecular size of single chain glycosaminoglycan was approximately 17,000 for case (A), while that for case (B) and normal subjects was approximately 23,000. When the D1 fraction was digested with chondroitin ABC lyase, approximately 71% of the radioactivity was degraded in case (A), indicating the amount of CS/DS. The rest remaining 29% which resisted the enzyme (Fig. 2 , bottom panel of A) probably represents HS. In case (B) and normal, the peaks of 35S at Kd=0.57 disappeared by the enzyme treatment (Fig. 3, bottom panel of B and normal), indicating that 35S was incorporated into glycosaminoglycan mainly composed of CS/DS proteoglycans. Approximately 8% of the radioactivity remained at the fraction between Kd=0.6 and 0.9 in case (B), representing HS proteoglycans. These results indicated that 
Discussion
Our results demonstrated that CS/DS or HS proteoglycan accumulated in the involved skin of PTM. The presence of hyaluronic acid was reported but the accumulation of sulfated proteoglycans was not clear in previous studies (Watson et al., 1947 , Cheung et al., 1978 and Jolliffe et al., 1979 . In the present investigation we have adopted the method by which isolation and characterization of cartilage proteoglycan was carried out (Hascall et al., 19741 and 1974b) . Namely, dissociative extraction of proteoglycans with 4M guanidine buffer containing detergent and protease inhibitors was employed. And then, sulfated glycosaminoglycan and proteoglycans were isolated with CsCl density gradient centrifugation. The covalant binding of glycosaminoglycan with protein was demonstrated by the decrease in molecular size after alkaline borohydride treatment which releases single chain glycosaminoglycan by the elimination reaction. The molecular size of the glycosaminoglycan was estimated from comparison of the peak elution position with known molecular weight glycosaminoglycans (Wasteson, 1971) . The constituents of glycosaminoglycan were examined in relation to its sensitivity to chondroitin ABC lyase. From the result described, we can conclude that PTM tissue accumulated proteoglycans with a molecular weight greater than a million (because it was excluded from Sepharose CL-6B) having a glycosaminoglycan chain size of approximately 70,000 M.W. The majority of the proteoglycan was CS/DS but a small amount of HS proteoglycans was observed as well. The accumulation of proteoglycan was demonstrated exclusively in the affected skin of PTM but not in the identical area of the hyperthyroid patient without PTM or of the patient with nonthyroid disease.
As the chondroitin sulfate proteoglycan is produced by skin fibroblasts and is mainly distributed in connective tissue, we have examined the biosynthesis of proteoglycan by cultured fibroblast employing [35S] sulfate incorporation into proteoglycans using the digestion. They did not provide any information on the recovery of radioactivity in each extraction step. The effect of alkaline borohydride and that of chondroitin ABC lyase by which the nature of glycosaminoglycan was to be characterized were not studied. Furthermore, they did not provide any information on whether fibroblasts from normal tissue were capable of synthesizing sulfated glycosaminoglycan. Our result is also contradictory to the report of Jolliffe et al, (1974) in which they reported that porated into cell compared to [3H] hexosamine and hence is not a good labeling precursor. Furthermore, their method of glycosaminoglycan extraction was repeating freezing and thawing whose efficiency for extraction of glycosaminoglycan associated with cell membrane is unknown. Our methods have been rigorously examined by Hascall and his associates (1974 a, b) and were accepted as a quantitative method for extraction and isolation of glycosaminoglycans and proteoglycans. Further study is required to determine the reason for the discrepancy concerning the effect of serum. Despite the use of strong denaturing conditions of 4 M guanidine HC1 and protease inhibitors throughout the extraction and purification procedure, a part of the 35S was incorporated into glycosaminoglycan present as single chain species in in vitro fibroblasts culture, suggesting proteolytic degradation of proteoglycans in the in vitro condition. This may represent the difference between in vivo conditions, where there is a clearance mechanism eliminating degraded proteoglycans, and in vitro conditions, where such mechanisms do not operate.
It is obvious that further study is required to elucidate the mechanism of proteoglycan accumulation in affected skin of PTM patients. 
